Medical experts discuss risk-based approaches to choosing MDS therapies.
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Advertisement
Articles by Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
4
Orexin Agonist Shows Promise for Treating Narcolepsy, Hypersomnia: Richard Bogan, MD
5